Medical Health & Life Science Research News

New report: Global blood screening market outlook till 2024

New report: Global blood screening market outlook till 2024

Blood screening is a medical process to scan and test the blood for a particular disease or condition. These tests are done for mostly for human immunodeficiency (HIV) screenings, pregnancy screenings, blood type screenings, general infections and cancer.

- Advertising -

Global Blood Screening Market, By Technology (Nucleic Acid Amplification, (rPCR), ELISA, (CLIA, Fluorescence assay), Rapid Test, NGS, Western Blotting), Product (Instrument, Reagent & Kits, Software) & End User (Blood Bank, Hospital), By Geography (North America, Europe, Asia-Pacific, Europe, South America, Middle East and Africa) – Industry Trends and Forecast to 2024

The blood screening market accounted to USD 1.76 billion in 2016 growing at a CAGR of 9.7% during the forecast period of 2017 to 2024

Request for Report @ databridgemarketresearch.com/reque…-screening-market Global Blood Screening Market – Market Segmentation:

By Technology the market for blood screening is segmented into NAT, enzyme-linked immunosorbent assay (ELISA), rapid tests, western blot assays, and next-generation sequencing (NGS). The Nucleic Acid Test (NAT) segment is further segmented into Transcription-Mediated Amplification (TMA) and Real-Time Polymerase Chain Reaction (PCR). 

The Enzyme-Linked Immunosorbent Assay (ELISA) segment is further segmented into by platform (Chemiluminescence Immunoassay (CLIA), Fluorescence Immunoassay (FIA), Colorimetric Immunoassay (CI)) and by generation (First-Generation ELISA, Second-Generation ELISA, Third-Generation ELISA, and Fourth-Generation & Above).

By product type the blood screening market is segmented into reagents & kits, instruments, and software & services.

- Advertising -

The reagents & kits segment is further segmented into enzymes and polymerases, standards and controls, probes and primers, buffers, nucleotides and solutions, labeling and detection reagents.

The reagents & kits segment is further segmented into immunosorbents, controls, conjugates (antigen or antibody-conjugated enzyme), substrates (of enzymes), and sample diluents and wash solutions. The Instruments segment is further segmented into Rental Purchase and Outright Purchase.

On the basis of end-user the market is segmented into blood banks and hospitals segments.

Browse Full Report with Details TOC @ databridgemarketresearch.com/repor…screening-market/ Based on geography, the market is segmented into five geographical regions:

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East and Africa.

The geographical regions are further segmented into 29 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and others.

Some of the major players operating in this market are

  1. Grifols, F. Hoffmann-La Roche
  2. Abbott Laboratories
  3. Biomérieux
  4. Bio-Rad Laboratories, Inc.
  5. Siemens AG
  6. Ortho Clinical Diagnostics, Inc.
  7. Thermo Fisher Scientific, Inc.
  8. Danaher Corporation
  9. Becton
  10. Dickinson and Company

Inquire Report @ databridgemarketresearch.com/inqui…-screening-market

News From

Data Bridge Market ResearchData Bridge Market Research
Category: Market Research Publishers and RetailersCompany profile: Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data bridge is an aftermath of sheer wi ...